Average Co-Inventor Count = 4.70
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,076 patents)
2. Immunex Corporation (5 from 451 patents)
3. Message Pharmaceuticals, Inc. (3 from 9 patents)
4. Janssen Biotech, Inc. (2 from 410 patents)
5. Janssen Pharmaceuticals, Inc. (2 from 159 patents)
6. National Institutes of Health (nih) (2 from 30 patents)
7. Raptor Pharmaceutical Corp (2 from 6 patents)
8. Other (1 from 832,680 patents)
9. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)
10. Dartmouth College (1 from 662 patents)
11. The National Institutes of Health and Axonyx, Inc. (1 from 1 patent)
12. Torreypines Therapeutics, Inc. (1 patent)
23 patents:
1. 12441801 - Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying same
2. 12188938 - Anti-VISTA antibodies and fragments
3. 12173064 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
4. 12139532 - Anti-human vista antibodies and use thereof
5. 11987630 - Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
6. 11649283 - Anti-human vista antibodies and use thereof
7. 11603402 - Anti-human vista antibodies and use thereof
8. 11603403 - Anti-human vista antibodies and use thereof
9. 11525000 - Anti-human VISTA antibodies and use thereof
10. 11242392 - Anti-vista antibodies and fragments
11. 11014987 - Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
12. 11009509 - Anti-VISTA antibodies and fragments
13. 10899836 - Method of identifying anti-VISTA antibodies
14. 10894830 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
15. 10273301 - Anti-vista antibodies and fragments